Search
for
Sort by
Research 91–120 of 520
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Alopecia areata – Current understanding and management
- Time-course RNA-seq analysis reveals stage-specific and melatonin-triggered gene expression patterns during the hair follicle growth cycle in Capra hircus
- Implication of microRNA regulation in para-phenylenediamine-induced cell death and senescence in normal human hair dermal papilla cells
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Exploring the Potential Role of Hydroxytyrosol in Androgenetic Alopecia: An Integrated Bioinformatics and Molecular Simulation Study
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Review of Promising Off-Label Use of Deucravacitinib
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Advances in the mechanism and new therapies of alopecia areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Treating Alopecia Areata: Current Practices Versus New Directions
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Alopecia areata: medical treatments
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata